Dementia Matters cover image

Our Evolving Understanding of Mild Cognitive Impairment

Dementia Matters

00:00

Alzheimer's Disease

In 2018, there was a foundational change in how scientists viewed Alzheimer's disease. It went from being a clinical entity with some persistent element of uncertainty to one that can be diagnosed by biomarkers and the like. This changes the field rather dramatically because now it's saying that somebody who is clinically normal, but harbors biologic changes of amyloid and tau, would be labeled as having Alzheimer’s disease.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app